OIG has updated its FAQs regarding the application of its administrative enforcement authorities to arrangements directly connected with COVID-19 with the addition of two new FAQs. On August 4, 2020, the OIG issued an FAQ...more
8/26/2020
/ Anti-Kickback Statute ,
Beneficiary Inducement ,
Clinical Laboratories ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Emergency Use Authorization (EUA) ,
Federal Health Care Programs (FHCP) ,
Food and Drug Administration (FDA) ,
OIG ,
Public Health ,
Public Health Emergency ,
Virus Testing